AIM ImmunoTech Files Provisional Patent Application for Ampligen as an Early-Onset Intranasal … – Tyler Morning Telegraph

27th September 2021

AIM ImmunoTech Files Provisional Patent Application for Ampligen as an Early-Onset Intranasal … Tyler Morning Telegraph